Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer

BACKGROUND: The prognostic value of patient-reported outcomes (PROs) has been minimally explored in advanced breast cancer (BC), and their comparative prognostic performance against Eastern Cooperative Oncology Group performance status (ECOG PS) is largely unknown. PATIENTS AND METHODS: This study p...

Descripción completa

Detalles Bibliográficos
Autores principales: Modi, N.D., Danell, N.O., Perry, R.N.A., Abuhelwa, A.Y., Rathod, A., Badaoui, S., McKinnon, R.A., Haseloff, M., Shahnam, A., Swain, S.M., Welslau, M., Sorich, M.J., Hopkins, A.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271483/
https://www.ncbi.nlm.nih.gov/pubmed/35490579
http://dx.doi.org/10.1016/j.esmoop.2022.100475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271483/
https://www.ncbi.nlm.nih.gov/pubmed/35490579
http://dx.doi.org/10.1016/j.esmoop.2022.100475

Ejemplares similares